Crypto sentiment is trapped in extreme fear because the industry’s biggest structural wins are failing to move prices
GeneralAmarin Urges Supreme Court to Reject Review of Skinny Label Patent DisputeAmarin Pharma Inc. on Tuesday asked the U.S. Supreme Court to decline review of a patent dispute involving generic drug “skinny labels,” arguing that the case centers on fact-specific issues that are ...wpadministratorDecember 25, 2025 Read More